CEDARS-SINAI MEDICAL CENTER
Synoviocyte endothelial cell cross talk in rheumatoid arthritis
Synoviocyte endothelial cell cross talk in rheumatoid arthritis is a funding opportunity from CEDARS-SINAI MEDICAL CENTER, up to 459250, closing May 31, 2027.
May 31, 2027
(304d left)Overview
ABSTRACT The management of rheumatoid arthritis (RA) has been transformed by immune targeted disease-modifying anti- rheumatic agents such as tumor necrosis factor alpha inhibitors. However, an unmet need persists for therapies that would be more tailored against local and disease-specific mechanisms and thus be less…